New York, NY -- (SBWIRE) -- 01/15/2014 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: WPCS International Incorporated (NASDAQ:WPCS), ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), CytRx Corporation (NASDAQ:CYTR), Enzon Pharmaceuticals Inc (NASDAQ:ENZN)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
WPCS International Incorporated (NASDAQ:WPCS) opened its shares at the price of $1.90 for the day. Its closing price was $1.81 after losing -2.16% for the day. The company traded with the total volume of 1.16 million shares, while its average trading volume remained 3.07 million shares. The beta of WPCS stands at 0.52. WPCS International Incorporated provides design-build engineering services for communications infrastructure worldwide.
Has WPCS Found The Bottom and Ready To Move Up? Find Out Here
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) percentage change plunged -2.00% to close at $0.951 with the total traded volume of 1.11 million shares, and average volume of 3.86 million. The 52 week range of the stock remained $0.65 - $4.00, while its day lowest price was $0.94 and it hit its day highest price at $0.97. ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, engages in developing and commercializing immune-based therapies for the treatment of brain, ovarian, and other solid tumors.
Has IMUC Found The Bottom And Ready To Gain Momentum? Find Out Here
CytRx Corporation (NASDAQ:CYTR) ended its day with the loss of -1.74% and closed at the price of $7.34 after opening at $7.94. Stock traded during its last trading session with the total volume of 2.27 million shares, as compared to its average volume of 6.06 million shares. CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. Its oncology pipeline includes two programs, aldoxorubicin and tamibarotene, which are in clinical development for cancer indications.
Will CYTR Get Buyers Even After The Recent Rally? Find Out Here
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) started its trading session with the price of $1.13 and closed at $1.13 by scoring -1.74%. ENZN’s stocks traded with total volume of 1.02 million shares, while the average trading volume remained 613,182.00 shares. The beta of ENZN stands at 0.83. Day range of the stock was $1.11 -$1.14. Enzon Pharmaceuticals, Inc. (Enzon) is a biotechnology company. The Company’s drug development programs utilize two platforms.
Why Should Investors Buy ENZN After the Recent Fall? Just Go Here and Find Out
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)